Amarin Corporation PLC Net Debt/EBITDA

Net Debt/EBITDA of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending June 30, 2022 was 5.95 (a -54.09% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA decreased by -102.29%
  • Annual Net Debt/EBITDA for 2021 was -33.46 (a -214.84% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was 29.14 (a 7.64% increase from previous year)
  • Annual Net Debt/EBITDA for 2019 was 27.07 (a 1574.25% increase from previous year)
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Amarin Corporation PLC

Most recent Net Debt/EBITDAof AMRN including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Amarin Corporation PLC

Amarin Corporation PLC Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 5.95 12.97
2021 -27.03 -260.23 -52.62 2968.73 -33.46
2020 -71.39 98.67 -107.4 21.51 29.14
2019 -95.33 157.98 80.55 6.25 27.07
2018 5.48 -1.44 -0.45 0.5 1.62
2017 -7.58 -5.89 -3.89 -1.78 -1.14
2016 -1.45 0.06 -15.23 -8.37 -0.31
2015 -8.56 -5.01 -4.08 -2.86 -1.52
2014 -6.28 -3.6 -2.76 -3.35 -1.28
2013 -2.43 -0.35 -1.95 -0.65 -0.42
2012 0.81 2.74 5.68 6.48 0.25
2011 9.48 13.35 2.64

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology